Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment.
Moon JH, Kim SN, Kang BW, Chae YS, Kim JG, Baek JH, Park JH, Song MK, Chung JS, Won JH, Lee SM, Joo YD, Kim YK, Kim HJ, Jo DY, Sohn SK.
Moon JH, et al. Among authors: baek jh.
Ann Hematol. 2010 Jul;89(7):681-9. doi: 10.1007/s00277-010-0921-5. Epub 2010 Mar 17.
Ann Hematol. 2010.
PMID: 20237926
Clinical Trial.